HK Stock MarketDetailed Quotes

02877 SHINEWAY PHARM

Watchlist
  • 9.350
  • +0.020+0.21%
Not Open Apr 25 16:09 CST
7.73BMarket Cap7.23P/E (TTM)

SHINEWAY PHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
14.32%4.52B
32.14%2.4B
22.56%3.95B
16.80%1.82B
21.38%3.22B
30.58%1.55B
-1.86%2.66B
-13.02%1.19B
5.28%2.71B
4.84%1.37B
Operating income
14.32%4.52B
32.14%2.4B
22.56%3.95B
16.80%1.82B
21.38%3.22B
30.58%1.55B
-1.86%2.66B
-13.02%1.19B
5.28%2.71B
4.84%1.37B
Cost of sales
-10.88%-1.12B
-21.28%-594.72M
-24.48%-1.01B
-20.47%-490.38M
-21.77%-813.21M
-29.74%-407.07M
7.81%-667.86M
20.16%-313.75M
-4.36%-724.43M
-4.55%-392.99M
Operating expenses
-10.88%-1.12B
-21.28%-594.72M
-24.48%-1.01B
-20.47%-490.38M
-21.77%-813.21M
-29.74%-407.07M
7.81%-667.86M
20.16%-313.75M
-4.36%-724.43M
-4.55%-392.99M
Gross profit
15.51%3.39B
36.17%1.8B
21.90%2.94B
15.50%1.32B
21.25%2.41B
30.88%1.15B
0.32%1.99B
-10.14%876.37M
5.62%1.98B
4.95%975.29M
Selling expenses
-8.96%-1.98B
-24.29%-1.03B
-21.27%-1.82B
-17.45%-824.8M
-26.51%-1.5B
-24.99%-702.24M
-5.22%-1.19B
1.30%-561.83M
-12.97%-1.13B
-13.47%-569.26M
Administrative expenses
-16.69%-326.5M
-8.13%-138.37M
-9.06%-279.8M
-13.23%-127.97M
6.15%-256.56M
10.65%-113.01M
0.84%-273.36M
9.94%-126.49M
-7.57%-275.66M
-8.34%-140.44M
Research and development expenses
5.95%-110.46M
-68.11%-48.2M
-4.21%-117.45M
-14.57%-28.67M
-13.04%-112.71M
-24.03%-25.03M
2.93%-99.71M
55.97%-20.18M
19.83%-102.72M
37.66%-45.83M
Impairment and provision
38.38%-5.44M
-332.16%-6.24M
-25.74%-8.83M
-174.86%-1.44M
97.03%-7.02M
84.94%-525K
-429.75%-236.52M
---3.49M
---44.65M
----
-Impairment of intangible assets
----
----
----
----
----
----
-368.71%-168.73M
----
---36M
----
-Impairment of property, machinery and equipment
----
----
----
----
----
----
---4.07M
----
----
----
-Goodwill impairment
----
----
----
----
----
----
---56.79M
----
----
----
-Other impairment is provision
38.38%-5.44M
-332.16%-6.24M
-25.74%-8.83M
-174.86%-1.44M
-1.53%-7.02M
84.94%-525K
20.03%-6.92M
---3.49M
---8.65M
----
Special items of operating profit
59.44%167.38M
117.03%28.85M
26.71%104.98M
-45.53%13.29M
-3.85%82.85M
-69.69%24.4M
-8.45%86.17M
-2.58%80.5M
142.77%94.13M
298.89%82.64M
Operating profit
38.96%1.14B
73.09%614.85M
32.62%818.56M
7.44%355.23M
121.25%617.22M
35.01%330.63M
-46.96%278.97M
-19.02%244.89M
-1.33%525.96M
23.34%302.4M
Financing cost
-334.44%-2.74M
50.43%-171K
49.76%-630K
73.42%-345K
92.45%-1.25M
90.28%-1.3M
-524.53%-16.6M
-8,405.73%-13.35M
---2.66M
---157K
Special items of earning before tax
6.47%105.51M
0.15%56.61M
-4.84%99.1M
10.64%56.53M
-21.50%104.14M
-27.30%51.09M
11.04%132.66M
47.30%70.28M
-12.19%119.47M
-35.15%47.71M
Earning before tax
35.25%1.24B
63.17%671.29M
27.35%917.03M
8.15%411.41M
82.29%720.1M
26.05%380.42M
-38.54%395.02M
-13.76%301.81M
-3.94%642.77M
9.80%349.96M
Tax
-39.38%-270.74M
-123.98%-179.82M
-18.86%-194.25M
-11.56%-80.29M
-63.44%-163.43M
-49.65%-71.97M
28.38%-99.99M
22.81%-48.09M
14.48%-139.62M
-0.96%-62.3M
After-tax profit from continuing operations
34.14%969.51M
48.42%491.47M
29.84%722.77M
7.35%331.12M
88.68%556.67M
21.57%308.46M
-41.36%295.03M
-11.80%253.72M
-0.54%503.15M
11.92%287.66M
Earning after tax
34.14%969.51M
48.42%491.47M
29.84%722.77M
7.35%331.12M
88.68%556.67M
21.57%308.46M
-41.36%295.03M
-11.80%253.72M
-0.54%503.15M
11.92%287.66M
Profit attributable to shareholders
34.14%969.51M
48.42%491.47M
29.84%722.77M
7.35%331.12M
88.68%556.67M
21.57%308.46M
-41.36%295.03M
-11.80%253.72M
-0.54%503.15M
11.92%287.66M
Basic earnings per share
33.33%1.28
47.73%0.65
29.73%0.96
7.32%0.44
89.74%0.74
24.24%0.41
-39.06%0.39
-8.33%0.33
3.23%0.64
16.13%0.36
Diluted earnings per share
33.33%1.28
47.73%0.65
29.73%0.96
7.32%0.44
89.74%0.74
24.24%0.41
-39.06%0.39
-8.33%0.33
3.23%0.64
16.13%0.36
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 14.32%4.52B32.14%2.4B22.56%3.95B16.80%1.82B21.38%3.22B30.58%1.55B-1.86%2.66B-13.02%1.19B5.28%2.71B4.84%1.37B
Operating income 14.32%4.52B32.14%2.4B22.56%3.95B16.80%1.82B21.38%3.22B30.58%1.55B-1.86%2.66B-13.02%1.19B5.28%2.71B4.84%1.37B
Cost of sales -10.88%-1.12B-21.28%-594.72M-24.48%-1.01B-20.47%-490.38M-21.77%-813.21M-29.74%-407.07M7.81%-667.86M20.16%-313.75M-4.36%-724.43M-4.55%-392.99M
Operating expenses -10.88%-1.12B-21.28%-594.72M-24.48%-1.01B-20.47%-490.38M-21.77%-813.21M-29.74%-407.07M7.81%-667.86M20.16%-313.75M-4.36%-724.43M-4.55%-392.99M
Gross profit 15.51%3.39B36.17%1.8B21.90%2.94B15.50%1.32B21.25%2.41B30.88%1.15B0.32%1.99B-10.14%876.37M5.62%1.98B4.95%975.29M
Selling expenses -8.96%-1.98B-24.29%-1.03B-21.27%-1.82B-17.45%-824.8M-26.51%-1.5B-24.99%-702.24M-5.22%-1.19B1.30%-561.83M-12.97%-1.13B-13.47%-569.26M
Administrative expenses -16.69%-326.5M-8.13%-138.37M-9.06%-279.8M-13.23%-127.97M6.15%-256.56M10.65%-113.01M0.84%-273.36M9.94%-126.49M-7.57%-275.66M-8.34%-140.44M
Research and development expenses 5.95%-110.46M-68.11%-48.2M-4.21%-117.45M-14.57%-28.67M-13.04%-112.71M-24.03%-25.03M2.93%-99.71M55.97%-20.18M19.83%-102.72M37.66%-45.83M
Impairment and provision 38.38%-5.44M-332.16%-6.24M-25.74%-8.83M-174.86%-1.44M97.03%-7.02M84.94%-525K-429.75%-236.52M---3.49M---44.65M----
-Impairment of intangible assets -------------------------368.71%-168.73M-------36M----
-Impairment of property, machinery and equipment ---------------------------4.07M------------
-Goodwill impairment ---------------------------56.79M------------
-Other impairment is provision 38.38%-5.44M-332.16%-6.24M-25.74%-8.83M-174.86%-1.44M-1.53%-7.02M84.94%-525K20.03%-6.92M---3.49M---8.65M----
Special items of operating profit 59.44%167.38M117.03%28.85M26.71%104.98M-45.53%13.29M-3.85%82.85M-69.69%24.4M-8.45%86.17M-2.58%80.5M142.77%94.13M298.89%82.64M
Operating profit 38.96%1.14B73.09%614.85M32.62%818.56M7.44%355.23M121.25%617.22M35.01%330.63M-46.96%278.97M-19.02%244.89M-1.33%525.96M23.34%302.4M
Financing cost -334.44%-2.74M50.43%-171K49.76%-630K73.42%-345K92.45%-1.25M90.28%-1.3M-524.53%-16.6M-8,405.73%-13.35M---2.66M---157K
Special items of earning before tax 6.47%105.51M0.15%56.61M-4.84%99.1M10.64%56.53M-21.50%104.14M-27.30%51.09M11.04%132.66M47.30%70.28M-12.19%119.47M-35.15%47.71M
Earning before tax 35.25%1.24B63.17%671.29M27.35%917.03M8.15%411.41M82.29%720.1M26.05%380.42M-38.54%395.02M-13.76%301.81M-3.94%642.77M9.80%349.96M
Tax -39.38%-270.74M-123.98%-179.82M-18.86%-194.25M-11.56%-80.29M-63.44%-163.43M-49.65%-71.97M28.38%-99.99M22.81%-48.09M14.48%-139.62M-0.96%-62.3M
After-tax profit from continuing operations 34.14%969.51M48.42%491.47M29.84%722.77M7.35%331.12M88.68%556.67M21.57%308.46M-41.36%295.03M-11.80%253.72M-0.54%503.15M11.92%287.66M
Earning after tax 34.14%969.51M48.42%491.47M29.84%722.77M7.35%331.12M88.68%556.67M21.57%308.46M-41.36%295.03M-11.80%253.72M-0.54%503.15M11.92%287.66M
Profit attributable to shareholders 34.14%969.51M48.42%491.47M29.84%722.77M7.35%331.12M88.68%556.67M21.57%308.46M-41.36%295.03M-11.80%253.72M-0.54%503.15M11.92%287.66M
Basic earnings per share 33.33%1.2847.73%0.6529.73%0.967.32%0.4489.74%0.7424.24%0.41-39.06%0.39-8.33%0.333.23%0.6416.13%0.36
Diluted earnings per share 33.33%1.2847.73%0.6529.73%0.967.32%0.4489.74%0.7424.24%0.41-39.06%0.39-8.33%0.333.23%0.6416.13%0.36
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg